• The Ecology of Medical Care in Poor Settings- Self Reported Health Care Utilization in Santiago Del Estero, Argentina

    Nov 1, 2013, 00:00

  • Bayesian Network Meta-Analysis to Assess Relative Efficacy and Safety of Canagliflozin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Metformin

    Nov 1, 2013, 00:00

  • Defining Standards of Clinician Qualifications for the Linguistic Validation of Clinical Outcome Assessments (COAs)

    Nov 1, 2013, 00:00

  • Applicability of Japanese Health Care Database to Clinical Trial Planning for Dyslipidaemia Drug

    Nov 1, 2013, 00:00

  • Systematic Literature Review and Cost-effectiveness Analysis of Fetal Fibronectin Test for Predicting Preterm in Brazil

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Insulin Degludec Compared with Current Standard of Care in the Management of Type 1 and Type 2 Diabetes Mellitus in the Spanish Health System

    Nov 1, 2013, 00:00

  • Survey Design in the Assessment of the Implementation of Risk Minimisation Measures for Medicinal Products

    Nov 1, 2013, 00:00

  • Bayesian Analysis of Malformation Outcome in Selective Serotonin Reuptake Inhibitor (SSRI) Use During Pregnancy- An Indirect Comparison of Citalopram, Fluoxetine, Paroxetine, and Sertraline

    Nov 1, 2013, 00:00

  • Pharmaco-Economic Education Needs Investigated by ISPOR Chapter – Example from Bulgaria

    Nov 1, 2013, 00:00

  • Estimation of the Number of Cases of Nosocomial Skin and Soft Tissue Infection in Adults Caused by Gram-Positive Bacteria in Public Hospitals in Mexico

    Nov 1, 2013, 00:00

  • Comparing Quality of Life and Clinical Variables for the Prediction of Future Medical Events

    Nov 1, 2013, 00:00

  • Uncertainty and Cost-Effectiveness Analysis of the Sequential Application of Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia

    Nov 1, 2013, 00:00

  • La Protección Financiera Y El Gasto De Bolsillo En Salud De La Población Mexicana 2002-2010

    Nov 1, 2013, 00:00

  • Treatment and Outcome Analysis of Rodenticide Poisoning in Tertiary Care Hospital in South India

    Nov 1, 2013, 00:00

  • Validating an Indolent Non-Hodgkin’s Lymphoma (NHL) Cost-Effectiveness Analysis Model Using Two Software Tools- Key Implementation Considerations and Results

    Nov 1, 2013, 00:00

  • Cost-minimization Analysis of Dienogest Versus Gonadotrophin-releasing Hormone Analogues or Dydrogesterone for Endometriosis Treatment in Russia

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of an Interface Geriatric Intervention- Acute Medical Unit Comprehensive Geriatric Assessment Intervention Study (AMIGOS)

    Nov 1, 2013, 00:00

  • A Unified Methodological Framework for the Economic Evaluation of Therapeutic Medical Devices

    Nov 1, 2013, 00:00

  • A Cost-Of-Illness Analysis of Hepatitis C in Greece

    Nov 1, 2013, 00:00

  • Análisis Del Impacto En La Demanda De Tecnologías Incluidas En El Plan De Beneficios Colombiano (POS) Posterior A Su Actualización En 2012

    Nov 1, 2013, 00:00

  • Can a Multi-Criteria Decision (MCD) Optimisation Model Help Decision Makers in the Optimal Selection of Vaccines When Expanding Their Universal Mass Vaccination Programme? The Case of Poland

    Nov 1, 2013, 00:00

  • Treatment Disparity Among Patients Diagnosed with Depressive Disorder in Working Population Based on Claims Database in Japan

    Nov 1, 2013, 00:00

  • Pharmacotherapy Costs of Multiple Myeloma in the Czech Republic- A Retrospective Analysis

    Nov 1, 2013, 00:00

  • Pricing and Reimbursment of Pharmaceuticals in Iran

    Nov 1, 2013, 00:00

  • Comparing Health-Related Quality of Life Across Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis- Analyses from Certolizumab Pegol Clinical Trial Baseline Data

    Nov 1, 2013, 00:00

  • Mode Equivalence of Interactive Voice Response (IVR) and Paper Versions of the Brief Pain Inventory (BPI) “Worst Pain” Item in Metastatic Castrate Resistant Prostate Cancer (mCRPC) Evaluated Conceptually Using Qualitative Methods

    Nov 1, 2013, 00:00

  • The German Quota System as a Model for Biosimilar Cost Savings in Epoetin Treatment

    Nov 1, 2013, 00:00

  • Evaluation of Associations Among Biomarkers, Correlates and Treatment Efficacy in Clinical Studies in Patients Diagnosed with Non-Psychotic Major Depressive Disorder- A Literature Review

    Nov 1, 2013, 00:00

  • Estimation of the Number of Cases of Nosocomial Pneumonia in Adults Caused by Gram-Positive Bacteria in Public Hospitals in Mexico

    Nov 1, 2013, 00:00

  • Direct and Indirect Costs of MS in Ireland

    Nov 1, 2013, 00:00

  • Cost-Outcome Description of Clinical Pharmacist Interventions in a University Teaching Hospital

    Nov 1, 2013, 00:00

  • Quality of Life (QOL) During Treatment of Newly Diagnosed Locally Confined Low-Risk Prostate Cancer (LCLRPC) in Germany- Results of the Harow Study

    Nov 1, 2013, 00:00

  • Unmet Needs and Biologic Use Among Patients with Rheumatoid Arthritis in Brazil

    Nov 1, 2013, 00:00

  • Evaluate the Status of Pharmacoeconomic Research Development in China from 2002 to 2013

    Nov 1, 2013, 00:00

  • Growth Mixture Modeling (GMM) to Determine Treatment Effects of Canagliflozin Versus Sitagliptin on Weight-Related Quality of Life (WRQoL) in Subjects with Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2013, 00:00

  • Outpatient Medical Costs, Indirect Costs, and Family Burden of Osteoporosis Fracture in China

    Nov 1, 2013, 00:00

  • Burden of Multiple Sclerosis and Unmet Needs in Brazil- Measurement of Fatigue Using Modified Fatigue Impact Scale

    Nov 1, 2013, 00:00

  • Dual Back Translation Versus Single Back-Translation Methodology When Translating Patient Reported Outcomes (PRO)

    Nov 1, 2013, 00:00

  • Health Care Resources Utilization in Alzheimer’s Disease- An Analysis with the Quebec Provincial Drug Reimbursement Program Database

    Nov 1, 2013, 00:00

  • Comparative Analysis of the Cost and Metabolic Control in Diabetic Children Using Insulin Pumps

    Nov 1, 2013, 00:00

  • Assessment of Burden of Illness Due to Herpes Zoster in Argentina- A Prospective Observational Study

    Nov 1, 2013, 00:00

  • Pharmacoeconomic Analysis of Abatacept for Treatment of Adults with Rheumatoid Arthritis in Russia

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Analysis of Glycopyrronium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease in Spain

    Nov 1, 2013, 00:00

  • Model-Based Economic Evaluations in Alzheimer’s Disease - A Review of Modeling Methods

    Nov 1, 2013, 00:00

  • Comparison Retail Prices of Drug Prices Between Turkey and European Countries

    Nov 1, 2013, 00:00

  • Is It Worth Having Orphan Drug Status in Germany Post-Amnog?

    Nov 1, 2013, 00:00

  • Incremental Cost Per Quality-adjusted Life Year Gained? The Need for Alternative Methods to Evaluate Medical Interventions for Ultra-rare Disorders

    Nov 1, 2013, 00:00

  • Qualidade De Vida Em Pacientestransplantados Renais

    Nov 1, 2013, 00:00

  • The List of Medicines for COPD Treatment in State Formulary of Ukraine and Related Costs

    Nov 1, 2013, 00:00

  • Predicting the Frequency of Severe and Non-Severe Hypoglycaemia in Insulin Treated Type-2 Diabetes Subjects

    Nov 1, 2013, 00:00

  • Health Care Cost of Type 2 Diabetes Patients in Gree Sub-Population Analysis

    Nov 1, 2013, 00:00

  • Long-Term Outcomes of Sofosbuvir (SOF) for the Treatment of Chronic Hepatitis C Infected (CHC) Patients

    Nov 1, 2013, 00:00

  • Etanercept Provides Improved Quality of Life Regardless of the Presence of Psoriatric Arthritis in Moderate/Severe Psoriasis Subjects from Central and Eastern Europe, Latin America and Asia

    Nov 1, 2013, 00:00

  • A Decision Analytic Markov Model to Evaluate the Health Outcomes of Sofosbuvir for Previously Untreated Patients and Those Without Treatment Options with Chronic Hepatitis C Virus Genotype 2 Infection

    Nov 1, 2013, 00:00

  • Análise De Impacto Orçamentário- Quanto Custaria Ao Sistema Público De Saúde Brasileiro Incrementar, Por Meio De Transplantes, O Tratamento Da Doença Renal Crônica Terminal?

    Nov 1, 2013, 00:00

  • A Systematic Review of the Effectiveness of Taxes in Preventing Obesity Trends

    Nov 1, 2013, 00:00

  • Direct Medical Costs and Health Care Resource Utilization Associated with Selected Antibiotic Treatment Pathways in Acute Bacterial Skin and Skin Structure Infections in the United States

    Nov 1, 2013, 00:00

  • Disentangling Effects on Fatal and Non-Fatal Cardiovascular Events Over Time

    Nov 1, 2013, 00:00

  • Economic Impact of Including Sequential Bevacizumab for the Treatment of Patients with Kirsten Ras Wild Type Unresectable Metastatic Colorectal Cancer in Four Latin American Countries

    Nov 1, 2013, 00:00

  • Assessing Non-Inferiority of Aclidinium Bromide 400 mG Bid Versus Tiotropium 18 mG and 5 mG Qd in Patients with Chronic Obstructive Pulmonary Disease (COPD) by Means of a Network Meta-Analysis

    Nov 1, 2013, 00:00

  • Reduction of Costs Associated with a New Dry-Powder Inhaler Formulation with Beclomethasone Dipropionate and Formoterol Combination for the Treatment of Asthma

    Nov 1, 2013, 00:00

  • Evolución En El Uruguay De Tazas De Utilización De Cateterismo Cardíaco Diagnostico Par a Cardiopatía Congénita En Menores De 18 Años (1995-2012)

    Nov 1, 2013, 00:00

  • Comparison of Methods to Identify Stage IIIB or IV Metastatic Lung Cancer Patients from Electronic Medical Records

    Nov 1, 2013, 00:00

  • Impacto Económico Y En Discapacidad Del Incrementro De Utilización De Trombolisis En El Cuidado Agudo De L Ictus Isquémico En Chile

    Nov 1, 2013, 00:00

  • Health-State Utilities in Measuring Health-Related Quality of Life Among Patients with Rheumatoid Arthritis in Taiwan

    Nov 1, 2013, 00:00

  • Application of Health Technology Assessment and Pharmacoeconomics in the Decision-Making Process in Selected Eu Member States

    Nov 1, 2013, 00:00

  • Full Cost of Plasma from Voluntary Non Remunerated Donors in Italy

    Nov 1, 2013, 00:00

  • Weight Loss of ≥3% in Type II Diabetes Patients Is Associated with Weight Change Property of Newly Prescribed Anti-Diabetic Medicine in Anti-Depressant Users Over a 12-Month Follow-Up Period

    Nov 1, 2013, 00:00

  • Efecto De La Determinación De La Concentración Capilar De Proteína C Reactiva En La Tasa De Prescripción De Antibióticos Para El Tratamiento De Infección De Vías Respiratorias Altas (Análisis De Costo-Efectividad)

    Nov 1, 2013, 00:00

  • Translation and Cultural Adaptation of the SF-6D Questionnaire for Use in Arabic-Speaking Countries

    Nov 1, 2013, 00:00

  • Measuring the Cost of Lost Productivity Due to Premature Cancer-related Mortality- A European Overview

    Nov 1, 2013, 00:00

  • Estimating the Cardiovascular Benefits of DPP-4 Inhibitors- A Simulated Study

    Nov 1, 2013, 00:00

  • Cost Utility Analysis of Everolimus in the Treatment of Metastatic Renal Cell Cancer in the Netherlands

    Nov 1, 2013, 00:00

  • Impact of Pharmacoeconomics Modelling on Reimbursement of Medicines in Serbia

    Nov 1, 2013, 00:00

  • Osteotomia De Acortamiento Radial En La Enfermedad De Kienbock (Seguimiento De 5 Años)

    Nov 1, 2013, 00:00

  • Budget Impact Analysis for the Use of Vandetanib in Mexican Adult Patient Diagnosed with Advanced Unresectable Medullary Thyroid Cancer

    Nov 1, 2013, 00:00

  • Collaborative Care for Depression Management in Cancer- A Cost-Effectiveness Analysis

    Nov 1, 2013, 00:00

  • Assessment of Cost-Effectiveness Models for Biologics in the Management of Psoriatic Arthritis

    Nov 1, 2013, 00:00

  • Overview of Coverage with Evidence Development in Sweden

    Nov 1, 2013, 00:00

  • Economic Burden of Axial Spondyloarthritis Related to Paid Work and Household Productivity at Baseline in the Rapid-axSpA Study- Differences and Similarities Between Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis

    Nov 1, 2013, 00:00

  • Hypercholesterolemia’s Burden of Disease in Portugal

    Nov 1, 2013, 00:00

  • Cost-Utility Analysis of Deferasirox for the Treatment of Iron Overload Due to Frequent Blood Transfusions in the Children and Adolescents

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Drug-Eluting Stents Versus Bare Metal Stents in Egyptian Diabetic Patients

    Nov 1, 2013, 00:00

  • Economic Evaluation of Sitagliptin in Diabetes Mellitus Treatment in China

    Nov 1, 2013, 00:00

  • Treatment Patterns of Chronic Lymphocytic Leukemia Patients Under the Brazilian Public Health Care Perspective

    Nov 1, 2013, 00:00

  • Health Care Costs of HIV in the Czech Republic. A Single Center Analysis

    Nov 1, 2013, 00:00

  • Cost-Effectiveness of Dapagliflozin as Add-On to Insulin for the Treatment of Type 2 Diabetes in the Netherlands

    Nov 1, 2013, 00:00

  • Health Related Quality of Life by Line of Therapy in Imatinib-Resistant or Imatinib-Intolerant Patients with Chronic Myeloid Leukemia Treated with Bosutinib Measured by EQ-5D

    Nov 1, 2013, 00:00

  • Treatment Persistence in Swedish Women Initiating Denosumab Treatment for Postmenopausal Osteoporosis

    Nov 1, 2013, 00:00

  • Comparison of Clinical Characteristics of Patients with Rheumatoid Arthritis Receiving Their First Biologic in Europe Union and the United States

    Nov 1, 2013, 00:00

  • Evaluation of the Length of Hospital Stay for Patients with Atrial Fibrillation

    Nov 1, 2013, 00:00

  • Results of the Post-Marketing Survey of Vildagliptin in France

    Nov 1, 2013, 00:00

  • The Relationship Between Scientific Research, Clinical Trials and FDA Drug Approval

    Nov 1, 2013, 00:00

  • Proposal of Economic Evaluation Guideline in Japan

    Nov 1, 2013, 00:00

  • Acute Asthma Characteristics and Asthma Control in Latin America

    Nov 1, 2013, 00:00

  • Economic Evaluation of Ivabradine for Chronic Heart Failure NYHA II to IV Class with Systolic Dysfunction in Ireland

    Nov 1, 2013, 00:00

  • Clinical and Cost-Effectiveness of Non-Pegylated Liposomal Doxorubicin for Non-Hodgkin Lymphoma- A Systematic Review

    Nov 1, 2013, 00:00

  • Estimation of the Cost-Effectiveness of Apixaban in Non-Valvular Atrial Fibrillation in Argentina

    Nov 1, 2013, 00:00

  • It Application for Post Marketing Drug Registries

    Nov 1, 2013, 00:00

  • Cultural Adaptation and Validation to Spanish of the “MS Treatment Concerns Questionnaire-MSTCQ”

    Nov 1, 2013, 00:00

  • Economic Activity of Cancer Survivors in Poland

    Nov 1, 2013, 00:00

  • A Comparative Study of the Role of Disease Severity in Drug Reimbursement Decision Making in Belgium, France, the Netherlands and Sweden

    Nov 1, 2013, 00:00

  • Geographical Inequalities in the Access to and Utilization of Home Care (Nursing) Services in Hungary

    Nov 1, 2013, 00:00

  • Translation and Cultural Adaptation of the Polish Version of “Disabilities of the Arm, Shoulder and Hand” (DASH) and Quickdash Questionnaires

    Nov 1, 2013, 00:00

  • The Importance of Safety Aspects in the Amnog Process in Germany- Is the G-Ba Assessment Consistent with That of the CHMP?

    Nov 1, 2013, 00:00

  • Recommendations for the Successful Linguistic Validation of Clinical Outcome Assessments for Limited Patient Populations

    Nov 1, 2013, 00:00

  • Approaches for Estimating Burden of Pneumococcal and Rotavirus Diseases- Conceptual Framework and Systematic Review

    Nov 1, 2013, 00:00

  • Crossover Adjustment in Oncology Trials Using a Rank Preserving Structural Failure Time Model (RPSFTM)- Wrapping Bootstraps Around Estimates of Life Expectancy for CE Models

    Nov 1, 2013, 00:00

  • Assessing Product Safety via Patient Based Active Surveillance (AS)- A Study in 30.000 Women Using Hormone Replacement Therapy (HRT)

    Nov 1, 2013, 00:00

  • Cost-Effectiveness Modelling of a 3-Month Tight Control Patient Management of Rheumatoid Arthritis with Certolizumab Pegol in France

    Nov 1, 2013, 00:00

  • Multi-state Statistical Modelling to Quantify an Individual-based Micro Simulation Model for Radiotherapy Treatment in Lung Cancer Patients

    Nov 1, 2013, 00:00

  • Incretin Therapy for Patients with Type 2 Diabetes in Spain- A Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin

    Nov 1, 2013, 00:00

  • Health Care Resource Utilization and Expenditures of Incident Breast Cancer Patients in the Netherlands- Retrospective Analysis of Health Insurance Data

    Nov 1, 2013, 00:00

  • Are Israeli Adults Willing to Pay Higher Health Taxes for a Wider Coverage of Life-Extending Medications?

    Nov 1, 2013, 00:00

  • Budget Impacts of Probiotics in Controlling Upper Respiratory Tract Infections in France

    Nov 1, 2013, 00:00

  • Comparison of the Prices Used in the Manufacturers’ Budget Impact Analyses and the Prices from Reimbursed Drugs List

    Nov 1, 2013, 00:00

  • Aflibercept in Neovascular (Wet) Age-Related Macular Degeneration- An Analysis of the Payer Decision Landscape

    Nov 1, 2013, 00:00

  • Compliance with Preventive Recommendations in Primary Care and Rate of Potentially Avoided Hospitalizations by Diabetes, Chronic Heart Failure or Chronic Pulmonary Obstructive Disease

    Nov 1, 2013, 00:00

  • Budget Impact Analysis of Fentanyl Buccal Tablet for the Treatment of Cancer Breaktrough Pain

    Nov 1, 2013, 00:00

  • Análisis De La Carga Financiera De Las Principales Enfermedades Reumatológicas

    Nov 1, 2013, 00:00

  • Benchmarks for Interpretation of Score Differences on the SF-36 Health Survey for Patients with Diabetes

    Sep 1, 2013, 00:00

  • Erratum

    Sep 1, 2013, 00:00

  • Cost-Utility of Metal-on-Metal Hip Resurfacing Compared to Conventional Total Hip Replacement in Young Active Patients with Osteoarthritis

    Sep 1, 2013, 00:00

  • Table of Contents

    Sep 1, 2013, 00:00

  • Economic Assessment of an Anti-HCV Screening Program in Italy

    Sep 1, 2013, 00:00

  • Priority Preferences: “End of Life” Does Not Matter, But Total Life Does

    Sep 1, 2013, 00:00

  • Complete Cytogenetic Response and Major Molecular Response as Surrogate Outcomes for Overall Survival in First-Line Treatment of Chronic Myelogenous Leukemia- A Case Study for Technology Appraisal on the Basis of Surrogate Outcomes Evidence ...

    Sep 1, 2013, 00:00

  • The Cloudy Crystal Ball of Cost-Effectiveness Studies

    Sep 1, 2013, 00:00

  • Improving Model Validation in Health Technology Assessment- Comments on Guidelines of the ISPOR-SMDM Modeling Good Research Practices Task Force

    Sep 1, 2013, 00:00

  • Performance of the UKPDS Outcomes Model for Prediction of Myocardial Infarction and Stroke in the ADDITION-Europe Trial Cohort

    Sep 1, 2013, 00:00

  • Early Scientific Advice Obtained Simultaneously from Regulators and Payers- Findings from a Pilot Study in Australia

    Sep 1, 2013, 00:00

  • Item-Level Psychometric Properties for a New Patient-Reported Psoriasis Symptom Diary

    Sep 1, 2013, 00:00

  • Cost-Effectiveness of Expanded Newborn Screening in Texas

    Sep 1, 2013, 00:00

  • Cost-Effectiveness of Boceprevir in Patients Previously Treated for Chronic Hepatitis C Genotype 1 Infection in the United States

    Sep 1, 2013, 00:00

  • Health State Valuation in Low- and Middle-Income Countries- A Systematic Review of the Literature

    Sep 1, 2013, 00:00

  • Editorial Board

    Sep 1, 2013, 00:00

  • Psychometric Properties and Measurement Equivalence of the English and Chinese Versions of the Functional Assessment of Cancer Therapy-Cognitive in Asian Patients With Breast Cancer

    Sep 1, 2013, 00:00

  • ISPOR-SMDM Task Force’s Recommendations for Good Modeling Practices—Reply to Letter to the Editor by Corro Ramos

    Sep 1, 2013, 00:00

  • Copyright/Subscription

    Sep 1, 2013, 00:00

  • Modeling SF-6D Hong Kong Standard Gamble Health State Preference Data Using a Nonparametric Bayesian Method

    Sep 1, 2013, 00:00

  • Reflections on Market Access for Personalized Medicine- Recommendations for Europe

    Sep 1, 2013, 00:00

  • Value-Based Assessment of Pharmacodiagnostic Testing from Early Stage Development to Real-World Use

    Sep 1, 2013, 00:00

  • Exploring the Consistency of the SF-6D

    Sep 1, 2013, 00:00

  • Genetic Screening for the Predisposition to Venous Thromboembolism- A Cost-Utility Analysis of Clinical Practice in the Italian Health Care System

    Sep 1, 2013, 00:00

  • Treatment Dynamics of Newly Marketed Drugs and Implications for Comparative Effectiveness Research

    Sep 1, 2013, 00:00

  • Title Page

    Sep 1, 2013, 00:00

  • Instructions for Authors

    Sep 1, 2013, 00:00

  • Lifetime Cost-Effectiveness of Trial of Labor After Cesarean in the United States

    Sep 1, 2013, 00:00

  • Editorial Board

    Sep 1, 2013, 00:00

  • Instructions for Authors

    Sep 1, 2013, 00:00

  • Copyright/Subscription

    Sep 1, 2013, 00:00

  • Regulation, Reimbursement, and the Long Road of Implementation of Personalized Medicine—A Perspective from the United States

    Sep 1, 2013, 00:00

  • Economic Incentives for Evidence Generation- Promoting an Efficient Path to Personalized Medicine

    Sep 1, 2013, 00:00

  • Program-Specific Cost-Effectiveness Analysis- Breast Cancer Screening Policies for a Safety-Net Program

    Sep 1, 2013, 00:00

  • The Development and Validation of a Multidimensional Sum-Scaling Questionnaire to Measure Patient-Reported Outcomes in Acute Respiratory Tract Infections in Primary Care- The Acute Respiratory Tract Infection Questionnaire

    Sep 1, 2013, 00:00

  • Advancing Pediatric Patient-Reported Outcome Assessment

    Sep 1, 2013, 00:00

  • Cost-Effectiveness of Expanded Newborn Screening in Texas—Author Response to Letter to the Editor

    Sep 1, 2013, 00:00

  • Cost-Effectiveness of Baseline Low-Dose Computed Tomography Screening for Lung Cancer- The Israeli Experience

    Sep 1, 2013, 00:00

  • Responsiveness of the Testing Morbidities Index in Colonoscopy

    Sep 1, 2013, 00:00

  • Personalized Medicine and the Role of Health Economics and Outcomes Research- Issues, Applications, Emerging Trends, and Future Research

    Sep 1, 2013, 00:00

  • Table of Contents

    Sep 1, 2013, 00:00

  • PHP97 Payer and Decision Maker Use of Observational Studies for Health Care Reimbursement Decisions

    Jul 1, 2013, 00:00

  • Table of Contents

    Jul 1, 2013, 00:00

  • Efficacy, Patient-Reported Outcomes (PROs), and Tolerability of the Changing Therapeutic Landscape in Patients with Metastatic Prostate Cancer (MPC)- A Systematic Literature Review

    Jul 1, 2013, 00:00

  • Deciding Which Drugs Get Onto the Formulary- A Value-Based Approach

    Jul 1, 2013, 00:00

  • Gastroprotective Strategies in Chronic NSAID Users- A Cost-Effectiveness Analysis Comparing Single-Tablet Formulations with Individual Components

    Jul 1, 2013, 00:00

  • Development and Initial Validation of the NCCN/FACT Symptom Index for Advanced Kidney Cancer

    Jul 1, 2013, 00:00

  • Validating and Improving the Reliability of the EORTC QLQ-C30 Using a Multidimensional Rasch Model

    Jul 1, 2013, 00:00

  • Italian Population-Based Values of EQ-5D Health States

    Jul 1, 2013, 00:00

  • Willingness to Pay for Diagnostic Technologies- A Review of the Contingent Valuation Literature

    Jul 1, 2013, 00:00

  • How Should We Deal with Patient Heterogeneity in Economic Evaluation- A Systematic Review of National Pharmacoeconomic Guidelines

    Jul 1, 2013, 00:00

  • Transarterial Chemoembolization Treatment- Association between Multiple Treatments, Cumulative Expenditures, and Survival

    Jul 1, 2013, 00:00

  • How Should We Value Future Health? Was NICE Right to Change?

    Jul 1, 2013, 00:00

  • Value of Research and Value of Development in Early Assessments of New Medical Technologies

    Jul 1, 2013, 00:00

  • Compensation Mechanisms for Lost Productivity- A Comparison between Four European Countries

    Jul 1, 2013, 00:00

  • Reviewing the Evidence to Inform the Population of Cost-Effectiveness Models within Health Technology Assessments

    Jul 1, 2013, 00:00

  • Copyright/Subscription

    Jul 1, 2013, 00:00

  • Editorial Board

    Jul 1, 2013, 00:00

  • Performance-Based Risk-Sharing Arrangements—Good Practices for Design, Implementation, and Evaluation- Report of the ISPOR Good Practices for Performance-Based Risk-Sharing Arrangements Task Force

    Jul 1, 2013, 00:00

  • Association between Health-Related Quality of Life and Body Mass After Adjustable Gastric Banding- A Nonlinear Approach

    Jul 1, 2013, 00:00

  • Health Utility Assessment Using EQ-5D among Caregivers of Children with Autism

    Jul 1, 2013, 00:00

  • Economic Analysis of the Intangible Impacts of Informal Care for People with Alzheimer’s Disease and Other Mental Disorders

    Jul 1, 2013, 00:00

  • Which Is More Valuable, Longer Survival or Better Quality of Life? Israeli Oncologists’ and Family Physicians’ Attitudes Toward the Relative Value of New Cancer and Congestive Heart Failure Interventions

    Jul 1, 2013, 00:00

  • Where Are We on “Risk-Sharing” Agreements?

    Jul 1, 2013, 00:00

  • Cost-Effectiveness of the 21-Gene Assay for Guiding Adjuvant Chemotherapy Decisions in Early Breast Cancer

    Jul 1, 2013, 00:00

  • Potential Cost-Effectiveness of Pneumococcal Conjugate Vaccine (PCV) in Turkey

    Jul 1, 2013, 00:00

  • Does the Process of Deliberation Change Individuals’ Health State Valuations? An Exploratory Study Using the Person Trade-Off Technique

    Jul 1, 2013, 00:00

  • Updating the Canadian Hemophilia Outcomes–Kids Life Assessment Tool (CHO-KLAT Version2.0)

    Jul 1, 2013, 00:00

  • A Systematic Literature Review of Psychosocial and Behavioral Factors Associated with Initial Medication Adherence- A Report of the ISPOR Medication Adherence Persistence Special Interest Group

    Jul 1, 2013, 00:00

  • Impact of Interventions on Medication Adherence and Blood Pressure Control in Patients with Essential Hypertension- A Systematic Review by the ISPOR Medication Adherence and Persistence Special Interest Group

    Jul 1, 2013, 00:00

  • Instructions for Authors

    Jul 1, 2013, 00:00

  • Value of Information Analysis from a Societal Perspective- A Case Study in Prevention of Major Depression

    Jun 1, 2013, 00:00

  • Table of Contents

    Jun 1, 2013, 00:00

  • Copyright/Subscription

    Jun 1, 2013, 00:00

  • Authors’ Response to “Comparative Effectiveness and Personalized Medicine” by Dr. J.C. Hornberger

    Jun 1, 2013, 00:00

  • Estimating the Effectiveness of HPV Vaccination in the Open Population- A Bayesian Approach

    Jun 1, 2013, 00:00

  • Examining Item Content and Structure in Health Status and Health Outcomes Instruments- Toward the Development of a Grammar for Better Understanding of the Concepts Being Measured

    Jun 1, 2013, 00:00

  • Using a Survey to Estimate Health Expectancy and Quality-Adjusted Life Expectancy to Assess Inequalities in Health and Quality of Life

    Jun 1, 2013, 00:00

  • QALY and Productivity Loss- Empirical Evidence for “Double Counting”

    Jun 1, 2013, 00:00

  • Evaluating the Cost-Effectiveness of Diagnostic Tests in Combination- Is It Important to Allow for Performance Dependency?

    Jun 1, 2013, 00:00

  • Probability Elicitation to Inform Early Health Economic Evaluations of New Medical Technologies- A Case Study in Heart Failure Disease Management

    Jun 1, 2013, 00:00

  • Cost-Effectiveness of New Oral Anticoagulants Compared with Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation

    Jun 1, 2013, 00:00

  • Instructions for Authors

    Jun 1, 2013, 00:00

  • Comparative Effectiveness in Personalized Medicine—Clearly Defining the Intended Use Population

    Jun 1, 2013, 00:00

  • Measuring the Quality of a Childhood Cancer Care Delivery System- Assessing Stakeholder Agreement

    Jun 1, 2013, 00:00

  • ePRO Systems Validation- Clearly Defining the Roles of Clinical Trial Teams and ePRO System Providers

    Jun 1, 2013, 00:00

  • Assessing the Value of Symptom Relief for Patients with Gastroesophageal Reflux Disease Treatment- Willingness to Pay Using a Discrete Choice Experiment

    Jun 1, 2013, 00:00

  • Measuring the Quality of a Childhood Cancer Care Delivery System- Quality Indicator Development

    Jun 1, 2013, 00:00

  • Radical Cystectomy versus Bladder-Preserving Therapy for Muscle-Invasive Urothelial Carcinoma- Examining Confounding and Misclassification Biasin Cancer Observational Comparative Effectiveness Research

    Jun 1, 2013, 00:00

  • The Mental Component of the Short-Form 12 Health Survey (SF-12) as a Measure of Depressive Disorders in the General Population- Results with Three Alternative Scoring Methods

    Jun 1, 2013, 00:00

  • Systematic Searching and Selection of Health State Utility Values from the Literature

    Jun 1, 2013, 00:00

  • Editorial Board

    Jun 1, 2013, 00:00

  • Digitization of Patient-Reported Outcomes

    Jun 1, 2013, 00:00

  • Computer Modeling of Diabetes and Its Complications- A Report on the Fifth Mount Hood Challenge Meeting

    Jun 1, 2013, 00:00

  • Cost-Effectiveness of Trabectedin Plus Pegylated Liposomal Doxorubicin for the Treatment of Women with Relapsed Platinum-Sensitive Ovarian Cancer in the UK- Analysis Based on the Final Survival Data of the OVA-301 Trial

    Jun 1, 2013, 00:00

  • Validation of Electronic Systems to Collect Patient-Reported Outcome (PRO) Data—Recommendations for Clinical Trial Teams- Report of the ISPOR ePRO Systems Validation Good Research Practices Task Force

    Jun 1, 2013, 00:00

  • A Checklist for Ascertaining Study Cohorts in Oncology Health Services Research Using Secondary Data- Report of the ISPOR Oncology Good Outcomes Research Practices Working Group

    Jun 1, 2013, 00:00

  • Cost-Effectiveness of Early Assisted Discharge for COPD Exacerbations in The Netherlands

    Jun 1, 2013, 00:00

  • Pediatric Patient-Reported Outcome Instruments for Research to Support Medical Product Labeling- Report of the ISPOR PRO Good Research Practices for the Assessment of Children and Adolescents Task Force

    Jun 1, 2013, 00:00

  • Using Whole Disease Modeling to Inform Resource Allocation Decisions- Economic Evaluation of a Clinical Guideline for Colorectal Cancer Using a Single Model

    Jun 1, 2013, 00:00

  • Reporting of Patient-Reported Outcomes in Randomized Trials- The CONSORT PRO Extension

    Jun 1, 2013, 00:00

  • Meta-Analysis of the Accuracy of Two Diagnostic Tests Used in Combination- Application to the Ddimer Test and the Wells Score for the Diagnosis of Deep Vein Thrombosis

    Jun 1, 2013, 00:00

  • Illustrating Potential Efficiency Gains from Using Cost-Effectiveness Evidence to Reallocate Medicare Expenditures

    Jun 1, 2013, 00:00

  • Health-Related Quality of Life of Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes—Results from the PLATO Trial

    Jun 1, 2013, 00:00

  • Cost-Saving Measures In Reimbursement Of Orphan Drugs Under Medicare Prescription Drug Plans

    May 1, 2013, 00:00

  • Comparative efficacy and safety of treatments for the management of overactive bladder- A systematic literature review and mixed treatment comparison

    May 1, 2013, 00:00

  • Cost-Effectiveness Analysis Of Etanercept Versus Available Anti-Tnf And Il-6 Blockers For Treating Rheumatoid Arthritis In Honduras

    May 1, 2013, 00:00

  • Cost-Effectiveness Analysis Of Using Levonorgestrel-Releasing Intrauterine System In Long-Term Contraception In Colombia

    May 1, 2013, 00:00

  • Trends in attention deficit hyperactivity disorder medication use and expenditures in the united states- An analysis of 2000-2010 medical expenditure panel data

    May 1, 2013, 00:00

  • Economic Burden Of Adverse Events In Patients Aged ≥65 Years Receiving Treatment For Metastatic Renal Cell Carcinoma (Mrcc)

    May 1, 2013, 00:00

  • Burden of disease associated with psoriasis in Colombia

    May 1, 2013, 00:00

  • The value of a good decision- Assessing the economic benefits of decision aids

    May 1, 2013, 00:00

  • Relationship between major bleeding and concurrent use of antiplatelet drugs with chinese medications

    May 1, 2013, 00:00

  • A cost-effectiveness analysis of transcatheter aortic-valve implantation (TAVI) compared to medical management for severe aortic stenosis in Colombia

    May 1, 2013, 00:00

  • Cost Analysis Model Between The Cobas Braf Test And Sanger Sequencing When Treating Malignant Melanoma Based On The Presence Of V600 Mutations

    May 1, 2013, 00:00

  • An Estimate Of The Health Economic Burden Of Unsatisfactory Cervical Cancer Screening Test Samples In A Population Of Women Between The Ages Of 21-65 Years In The United States

    May 1, 2013, 00:00

  • Systematic literature review of the temporal relationship between nsaid use and gastrointestinal, cardiovascular, or renal events

    May 1, 2013, 00:00

  • Age And Gender Distribution Of Outpatient Care Physiotherapy Services For Traumatic Injuries In Hungary

    May 1, 2013, 00:00

  • Assessing Quality Of Life In Atopic Dermatitis Pediatric Patients Across 12 Countries In The Asia Pacific Region

    May 1, 2013, 00:00

  • Effect of statins in delaying the progression of diabetic kidney disease- Systematic review of randomized controlled trials

    May 1, 2013, 00:00

  • Clinical Characteristics, Quality Measure Attainment, And Diabetes-Related Health Care Costs In Elderly Versus Overall People Living With Type-2 Diabetes Mellitus (T2dm) Receiving Metformin (Met) And Sulfonylurea (Su)

    May 1, 2013, 00:00

  • Potential Medical Cost Savings Associated With Routine Hospital-Based Use Of A Rapid Diagnostic Tool For Bloodstream Infection In The United States

    May 1, 2013, 00:00

  • Treatment Burden Associated With Peginterferon-Based Antiviral Therapy For Patients With Chronic Hepatitis C (Chc) In Japan

    May 1, 2013, 00:00

  • Development of an inhibitor-specific questionnaire for the assessment of health-related quality of life in haemophilia patients with inhibitors (INHIB-QoL)

    May 1, 2013, 00:00

  • DRG system in Italy- Evaluation Of Different Reimbursements For Surgical Procedures At National, Regional And Hospital Level

    May 1, 2013, 00:00

  • Translatability Assessment Of The Youth Quality-Of-Life Instrument–Weight Module (YQOL-W)

    May 1, 2013, 00:00

  • Demographic Characteristics Of Asthma Subjects That Step-Down From Fluticasone Propionate-Salmeterol Combination Therapy

    May 1, 2013, 00:00

  • Survival Of Patients With Advanced Melanoma In A Real World Setting

    May 1, 2013, 00:00

  • A systematic review on the quality of pharmacoeconomics studies in China

    May 1, 2013, 00:00

  • Health insurance cost of parkinson disease in Hungary- A cost of illness study

    May 1, 2013, 00:00

  • Are canadians different from americans in stated preferences for health? valuing EQ-5D-5L health states using discrete choice experiments

    May 1, 2013, 00:00

  • The Burden Of Glaucoma And Its Complications- A Large Population-Based Cohort Study

    May 1, 2013, 00:00

  • A European Assessment Of The Impact Of Inadequate Pain Relief (Ipr) On Health-Related Quality Of Life (Qol) In Patients With Knee Osteoarthritis (Oa) In The Survey Of Real World Therapies (Sort)

    May 1, 2013, 00:00

  • Prescription Drugs And Discounts- The Pharmacist's View

    May 1, 2013, 00:00

  • Forecasting The Health And Health Spending Consequences Of Value-Based Drug Insurance Design For Insureds With Five High-Cost Conditions

    May 1, 2013, 00:00

  • How can we use discrete event simulation to improve access to health care- an assessment of increasing access to care for children with medically refractory epilepsy

    May 1, 2013, 00:00

  • Hidden barriers to delivery of pharmacologic venous thromboembolism prophylaxis- The role of nursing beliefs and practices

    May 1, 2013, 00:00

  • Analysis of the impact of prescription synchronization on adherence among medicaid beneficiaries

    May 1, 2013, 00:00

  • Prevalence of depression in a West African country-Evidence from World Health Survey

    May 1, 2013, 00:00

  • Estimation of long-term care needs in patients under maintenance hemodialysis

    May 1, 2013, 00:00

  • Parents' Expectation To Receive Antibiotic Prescription For Children

    May 1, 2013, 00:00

  • Impact of hurricane katrina on epilepsy patients in the louisiana medicaid population

    May 1, 2013, 00:00

  • Modeling the economic implications of alternative treatments and care locations for acute bacterial skin and skin structure infections- Results from a discrete event simulation

    May 1, 2013, 00:00

  • Patient-centered outcomes in late-stage oncology indications – are manufacturers focusing on the patient?

    May 1, 2013, 00:00

  • Public health impact and cost effectiveness of hepatitis a vaccination in the united states- A population-based dynamic model

    May 1, 2013, 00:00

  • Abdominal Aortic Aneurysm Screening- How Many Life Years Lost From Underuse Of The Medicare Screening Benefit?

    May 1, 2013, 00:00

  • The Effect Of Copayments For Prescriptions On Adherence To Medicines In Publicly Insured Populations- A Systematic Review And Meta-Analysis

    May 1, 2013, 00:00

  • A review of cardiovascular disease health state utilities reported in cost-utility analyses 2000 – 2010

    May 1, 2013, 00:00

  • Impact Of Place Of Delivery On Neonatal Mortality In Rural Tanzania

    May 1, 2013, 00:00

  • A Systematic Review Of Diagnostic Accuracy Of Fdg Pet/Pet-Ct For Fever Of Unknown Origin

    May 1, 2013, 00:00

  • Orphan Disease Drug Costs In The United States- Assessment Of Launch Pricing Trends In Non-Cancer Orphan Diseases And The Future Implications On Health System Access

    May 1, 2013, 00:00

  • Cost Of Metastatic Castration-Resistant Prostate Cancer In The United States

    May 1, 2013, 00:00

  • Propensity score analysis in MEPS 2003-2010- PCS and MCS scores after migraine treatments

    May 1, 2013, 00:00

  • Cost-Effectiveness Of Mometasone Furoate Nasal Spray In The Treatment Of Rhinosinusitis In Mexico

    May 1, 2013, 00:00

  • Impact Of Abortion Complications On Health-Related Quality Of Life In Uganda

    May 1, 2013, 00:00

  • Attitudes Towards The Role Of Community Pharmacists In Iraq

    May 1, 2013, 00:00

  • Stated time-allocation, adherence, and health-outcome tradeoff preferences in cystic fibrosis households

    May 1, 2013, 00:00

  • Estimating an EQ-5D-3L value set in Singapore

    May 1, 2013, 00:00

  • Fluoroquinolone-Associated Tendon-Rupture- A Summary Of Reports In The Food And Drug Administration's (Fda's) Adverse Event Reporting System

    May 1, 2013, 00:00

  • Penicillin and amoxicillin prophylaxis in children with sickle cell disease (SCD)- compliance and cost comparison

    May 1, 2013, 00:00

  • Reemphasizing The Economics In Pharmacoeconomics

    May 1, 2013, 00:00

  • Ifosfamide Treatment Of Patients With Soft Tissue Sarcoma- Health Care Utilization And Cost Implications

    May 1, 2013, 00:00

  • Assessing The Geographic And Demographic Variation Associated With Psoriatic Arthritis Prevalence In The Veteran Population In The United States

    May 1, 2013, 00:00

  • Outpatient Visits For Schizophrenia In The United States- A Nationally Representative Analysis Using Namcs And NHAMES Data

    May 1, 2013, 00:00

  • Multi-Payers Comparison Of Daily Reimbursement Values Of Distinct Hospital Facilities In The Brazilian Private Health System

    May 1, 2013, 00:00

  • Budget impact analysis of linezolid in the treatment of complicated skin and soft tissue infections (cssti) in chile – Public scenario

    May 1, 2013, 00:00

  • Valuing EQ-5D-5L- Can latent utilities derived from a discrete choice model be transformed to health utilities derived from time trade-off tasks?

    May 1, 2013, 00:00

  • Issues In The Selection Of Comparators For Regulatory And Hta Submissions

    May 1, 2013, 00:00

  • Using real-world claims data for planning oncology clinical trials

    May 1, 2013, 00:00

  • Care pathway and cost for absssi subjects with antibiotic treatment in the united states- An analysis of a real world database

    May 1, 2013, 00:00

  • PAYER PERSPECTIVES ON DRUG PRICING, COVERAGE, AND REIMBURSEMENT IN OPHTHALMOLOGIC ORPHAN CONDITION IN THE UNITED STATES

    May 1, 2013, 00:00

  • Economic evaluation of using branded taxotere® versus. generic docetaxel- Based on decision tree model

    May 1, 2013, 00:00

  • Different Stakeholder Perspectives On Pharmacogenomic Testing

    May 1, 2013, 00:00

  • Clinical outcome of flouoro-2,deoxy-glucose positron emmission tomography/ computed tomography [FDG PET/CT] in breast cancer patients- study based on its refferal pattern

    May 1, 2013, 00:00

  • Ethics And Economics In Health Care Decision Making

    May 1, 2013, 00:00

  • Concomitant statin use with ezetimibe or colesevelam for treatment of hypercholesterolemia

    May 1, 2013, 00:00

  • Minimally Invasive Cosmetic Procedures- Patient Motivation And Satisfaction

    May 1, 2013, 00:00

  • Comparative analysis of direct cost studies on rheumatoid arthritis in Turkey

    May 1, 2013, 00:00

  • Cost-Effectiveness Of Intravitreal Aflibercept Injection (IAI) In Treating Neovascular Age-Related Macular Degeneration In The US

    May 1, 2013, 00:00

  • Diabetes and severity of coronary artery disease- assessment of clinical, epidemiologic, and angiographic characteristics

    May 1, 2013, 00:00

  • The Relationship Between Nurse Staffing And Patient Satisfaction In Emergency Departments

    May 1, 2013, 00:00

  • Costs associated with intravenous patient controlled analgesia (IV-PCA) in us hospitals

    May 1, 2013, 00:00

  • HTA Process In Brazil- How Far The Submitters Are From The Inclusion In The System?

    May 1, 2013, 00:00

  • Identifying accurate patient-based health and social care costs of older people for trial-based economic evaluation- Is it really worth it?

    May 1, 2013, 00:00

  • Quality Of Life In Rheumatoid Arthritis- How Much Do We Really Know?

    May 1, 2013, 00:00

  • Impact of dosage strength on medication persistence among patients treated with buprenorphine transdermal system

    May 1, 2013, 00:00

  • Patient Burden Associated With Wet Age-Related Macular Degeneration In Japan

    May 1, 2013, 00:00

  • Continued Declines In Mortality Are Largely Due To Reductions In Non-Aids Related Deaths, And Mortality Remains Disproportionately Higher Among Blacks And The Publicly Insured In The Hiv Outpatient Study (Hops), 1996–2009

    May 1, 2013, 00:00

  • Economic Analysis Of The Mexican's Institute For Social Security (IMSS) Expenditure

    May 1, 2013, 00:00

  • Impact Of Severe And Very Severe Chronic Obstructive Pulmonary Disease (Copd) On Health-Related Quality Of Life (Hrqol) And Work Productivity- Results Of A Nationally Representative Patient Survey And Chart Review Of Recently Exacerbating P ...

    May 1, 2013, 00:00

  • Insulin glargine is cost-effective in treatment of patients with diabetes type-2 in whom nph insulin does not provide adequate glycaemic control – The case of poland

    May 1, 2013, 00:00

  • Cost–Effectiveness Of A Mailed Advance Notification Letter To Increase Colorectal Cancer Screening

    May 1, 2013, 00:00

  • Clinical and economic assesment of the effectiveness of entecavir in comparison with pegylated interferon, lamivudine, telbivudine, tenofovir in treatment of chronic viral hepatitis in Russian federation

    May 1, 2013, 00:00

  • Estimating Development Cost Of An Interactive Website Based Cancer Screening Promotion Program

    May 1, 2013, 00:00

  • Evaluation of economic and medical consequences of the rotary left ventricular assist device with a discharge at home in France

    May 1, 2013, 00:00

  • The patient perception of intensity of urgency scale (PPIUS)- Its validation in men with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH)

    May 1, 2013, 00:00

  • Do asians have similar health-state preference? A study of mainland chinese and singaporeans

    May 1, 2013, 00:00

  • Variances in the rate of face, internal, and third party model validity by type of publication, type of model, and geographic region

    May 1, 2013, 00:00

  • Pharmacoeconomic Analysis Of Docetaxel In The Adjuvant Therapy Of Breast Cancer

    May 1, 2013, 00:00

  • Economic evaluations of antiretroviral therapy monitoring using routine hiv viral load testing in low-income settings- A systematic review

    May 1, 2013, 00:00

  • Geographic variation in diagnosis, medication use and associated costs of attention deficit disorder (ADD)

    May 1, 2013, 00:00

  • Prioritization Of In Vitro Diagnostic Tests For Updating Health Coverage In Colombia

    May 1, 2013, 00:00

  • Impact on health-related quality of life in multiple sclerosis patients due to a managed care program in Colombia

    May 1, 2013, 00:00

  • Time-specific propensity score analysis for observational study- A case study estimating the effectiveness of thiazolidinedione use

    May 1, 2013, 00:00

  • Application of reclassification measures in comparing risk adjustment models

    May 1, 2013, 00:00

  • Influence of pharmacist mediated medication counseling on medication adherence behavior in hypertensive patients at a south indian tertiary care teaching hospital

    May 1, 2013, 00:00

  • Meta-Analysis Of Nephrotoxicity In Patients With Solid Tumors Treated With Cisplatin Versus Non-Cisplatin Regimens With Sub-Group Analyses Based On Renal Eligibility Criteria

    May 1, 2013, 00:00

  • Review of cost-utility analyses in Asia

    May 1, 2013, 00:00

  • How do pharmaceutical margins vary by region, therapeutic area and country gross domestic product?

    May 1, 2013, 00:00

  • Disease Burden Of Idiopathic Chronic Cough (Icc) And Chronic Cough (Cc) In Copd, Ipf And Lung Cancer (Lc)- An Exploratory Literature Review

    May 1, 2013, 00:00

  • The Evolution Of Outcomes Guarantees, Do They Align With The Principles Of The Affordable Care Act (ACA)?

    May 1, 2013, 00:00

  • Public Engagment Mechanisms In Health Technology Assessment (HTA)- An Early Assessment Of Canada's National HTA Public Engagement Initiatives

    May 1, 2013, 00:00

  • The development and validation of a revised version of the medical outcomes study cognitive functioning scale (MOS-COG-R)

    May 1, 2013, 00:00

  • Examining the rate of myocardial infarction and associated costs in patients concomitantly receiving clopidogrel and various ppis- A retrospective claims analysis

    May 1, 2013, 00:00

  • The Introduction Of Biosimilar Monoclonal Antibodies Into Developed Markets- What Are Payers Concerned About?

    May 1, 2013, 00:00

  • Assessing The Implementation Of Nice Guidan Is There A Correlation Between Recommendations And Uptake In Clinical Practice?

    May 1, 2013, 00:00

  • Impact Of Comparative Effectiveness Research On Biomedical Innovation And Population Health

    May 1, 2013, 00:00

  • Impact of initiating statin therapy at a high dose – A retrospective observational study populations in the United Kingdom

    May 1, 2013, 00:00

  • Changes In The Number Of Enrolees In The Hungarian Managed Care Programme

    May 1, 2013, 00:00

  • Patient preferences for therapies in Epilepsy

    May 1, 2013, 00:00

  • Estimating The Cost For Prostate Cancer (Pca) Screening Using The Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial Data

    May 1, 2013, 00:00

  • Determining Economic Impact Of A Pharmacist-Led It-Based Intervention With Simple Feedback In Reducing Rates Of Clinically Important Errors In Medicines Management In General Practices (PINCER)

    May 1, 2013, 00:00

  • Clinical and neuroradiological effect of BG-12 (dimethyl fumarate) in subgroups of patients with relapsing–remitting multiple sclerosis (RRMS)- An integrated analysis of the phase 3 define and confirm studies

    May 1, 2013, 00:00

  • Assesing parameter importance in health economics models. Can we make it faster?

    May 1, 2013, 00:00

  • Disease burden of atrial fibrillation, Colombia 2000-2009

    May 1, 2013, 00:00

  • Type 2 Diabetes Patient Characteristics By Race/Ethnicity

    May 1, 2013, 00:00

  • All cause and disease-specific health care utilization and costs for medicaid beneficiaries with schizophrenic disorder before and after initiation of clozapine

    May 1, 2013, 00:00

  • Physician's adherence to the 2009 AHA/ACC guidelines in acute myocardial infarction (AMI) in cardiac care unit of a private tertiary health care setting in Northern India

    May 1, 2013, 00:00

  • Demographic and clinical characteristics, and treatment of cardiovascular risk factors among U.S. elderly patients with high-risk vascular disease

    May 1, 2013, 00:00

  • Adherence To Therapy Among Diabetes Patients In A Niger Delta Referral Center

    May 1, 2013, 00:00

  • Trends In Publication Of Comparative Value Assessments For Interventions In Cancer, Diabetes And Cardiovascular Diseases From 2010 To 2012

    May 1, 2013, 00:00

  • Evaluation of clinical and treatment characteristics and the economic burden of anxiety in veteran patients in the United States

    May 1, 2013, 00:00

  • How much is fatigue associated with anemia

    May 1, 2013, 00:00

  • Nonadherence And Treatment Interruption Of Tyrosine Kinase Inhibitors Association With Health Care Resource Cost And Utilization In Chronic Myeloid Leukemia Patients

    May 1, 2013, 00:00

  • Economic evaluation of prophylactic treatment versus on demand for severe hemophilia a in Colombia

    May 1, 2013, 00:00

  • Expanding concepts of opioid-taking behavior in sickle cell disease- A multi-phase, mixed methods study

    May 1, 2013, 00:00

  • Use Of Anti-Infectives For Systemic Administration In Serbia In 2011

    May 1, 2013, 00:00

  • Utility Values For Specific Chronic Myelogenous Leukaemia (Cml) Chronic Phase Health States Elicited From The General Public In The United Kingdom

    May 1, 2013, 00:00

  • Assessment Of The Incidence Of Flares For Gouty Arthritis Patients Within The Scott White Health Care System

    May 1, 2013, 00:00

  • Approaches to pain management among older and younger adults experiencing moderate to severe pain in a national health survey- Too much or not enough?

    May 1, 2013, 00:00

  • Transformation Of Services And Care Pathway Redesign In The NHS- Further Reforms In Health Policy

    May 1, 2013, 00:00

  • Impact Of South Carolina's Prescription Drug Monitoring Program On The Use Of Benzodiazepines In A Commercially Insured Population

    May 1, 2013, 00:00

  • Knowledge, awareness and attitudes to rational use of drug of patients and its influential factors in Beijing, China

    May 1, 2013, 00:00

  • Factors Associated With Initiation Of Testosterone Replacement Therapy In Aging Males

    May 1, 2013, 00:00

  • Drug Interactions In Elderly Population In Primary Health Care

    May 1, 2013, 00:00

  • Cost-Effectiveness Of Vaginal Progesterone Gel In Reducing Preterm Birth- A Decision Analytic Model Based On The Pregnant Randomized Clinical Trial

    May 1, 2013, 00:00

  • Identifying primary non-adherence rates of hmg-coa reductase inhibitors (statins)

    May 1, 2013, 00:00

  • Indirect costs of schizophrenia for community-dwelling texas residents

    May 1, 2013, 00:00

  • Cost Per Treated Patient For Biologics In Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis And Ankylosing Spondylitis Using Claims Data

    May 1, 2013, 00:00

  • Assessment Of Patients' Knowledge Of Drug Therapy In A Nigerian Health Care Facility

    May 1, 2013, 00:00

  • Budgetary Impact Of Intravitreal Aflibercept Injection (IAI) In Treating Neovascular Age-Related Macular Degeneration In A US Health Plan Of Adults Ages 65 Years And Older

    May 1, 2013, 00:00

  • Prescribing Pattern Of Clinicians In Private Health Facilities- An Assessment For Rational Drug Use

    May 1, 2013, 00:00

  • Homeless Patients Use Of Urban Emergency Departments In The United States

    May 1, 2013, 00:00

  • Electronic patient reported outcomes (epro)- The best defense in preventing missing pro data

    May 1, 2013, 00:00

  • Treatment patterns in pediatric antibiotic formulations- An analysis of the ramq database

    May 1, 2013, 00:00

  • Medication Utilization To Antidepressants Among Dual Eligibles Before And After Part D

    May 1, 2013, 00:00

  • Modeling And Analytics Framework For Value Based Pricing

    May 1, 2013, 00:00

  • Effectiveness Of The Monovalent Rotavirus Vaccine In Colombia Through Different Analyses Within An Ecological Study

    May 1, 2013, 00:00

  • which is more valuable, longer survival or better quality of life? Israeli oncologists' and family physicians' attitudes toward the relative value of new cancer and gongestive heart failure interventions

    May 1, 2013, 00:00

  • Treatment Modalities For Hepatocellular Carcinoma- Cumulative Expenditures And Survival In Seer-Medicare

    May 1, 2013, 00:00

  • Analysis Of The Waxman-Hatch Act Pharmaceutical Patent Extensions (1984–2012)

    May 1, 2013, 00:00

  • Balloon Catheter Dilation For Chronic Rhinosinusitis Does Not Increase The Frequency Of Sinus Surgeries In The United States

    May 1, 2013, 00:00

  • Implementation Of Quality Improvement Interventions For Pressure Ulcer Prevention In University Healthsystem Consortium Hospitals

    May 1, 2013, 00:00

  • Impact Of Opioid-Induced Constipation- A Multinational Cross-Sectional Survey Of Patients And Health Care Providers

    May 1, 2013, 00:00

  • The Notion Of Representative Languages In The Context Of Translatability Assessment

    May 1, 2013, 00:00

  • Costs associated with breakthrough pain in cancer patients- findings from the national breakthrough pain survey

    May 1, 2013, 00:00

  • Clinical And Economic Burden Of Chronic Obstructive Pulmonary Disease In Veteran Patients In The United States- A Real-World Evaluation

    May 1, 2013, 00:00

  • Systematic review of cost-effectiveness analyses of dabigatran versus warfarin for atrial fibrillation across different health care systems

    May 1, 2013, 00:00

  • Medication Adherence And Cd4 Response In Patients Receiving Antiretroviral Therapy

    May 1, 2013, 00:00

  • A Proportional Rule For Determining Ceiling Prices Of New Innovative Drugs

    May 1, 2013, 00:00

  • Self-Rated Health Measures With Different Reference Points And Mortality

    May 1, 2013, 00:00

  • Adjusting For Inflation In Economic Evaluations Of Health Technologies- Are We Doing It Wrong?

    May 1, 2013, 00:00

  • Cost-Effectiveness Analysis In German Pharmaceutical Price Regulation

    May 1, 2013, 00:00

  • Comparative safety and effectiveness of catheter ablation versus surgery for newly diagnosed atrial fibrillation

    May 1, 2013, 00:00

  • Economic Evaluation Of Linezolid Versus Vancomycin For Ventilator-Associated Pneumonia Patients In Guatemala

    May 1, 2013, 00:00

  • Assessment of drug related problems (DRP) in prescriptions received by patients suffering from chronic diseases dwelling in a south indian rural community

    May 1, 2013, 00:00

  • Utilization of polypill for management of myocardial infarction

    May 1, 2013, 00:00

  • Patients with nocturia – increasing time to first void improves sleep quality

    May 1, 2013, 00:00

  • The Cost-Effectiveness Of Companion Diagnostics In Cancer Therapy

    May 1, 2013, 00:00

  • Agency Agreement In Health Technology Assessment Reimbursement Decisions

    May 1, 2013, 00:00
  • «
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109 (current)
  • 110
  • »